Zdrowie i gospodarka · 21/03/2024
FDA Releases Draft Guidance on Real-World Evidence for Non-Interventional Studies of Drug and Biological Products
The FDA is releasing a draft guidance on the use of non-interventional studies, also known as observational studies, to demonstrate the effectiveness and safety of pharmaceutical products, as part of its Real-World Evidence (RWE) Program.
Source: Federal Register — Food and Drug AdministrationOpen original release →